首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Endocrinology, diabetes and metabolism

缩写:

ISSN:N/A

e-ISSN:2398-9238

IF/分区:2.6/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引613
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Behnaz Abiri,Mohammad Nikoohemmat,Maryam Mahdavi et al. Behnaz Abiri et al.
Background: Uncertainty surrounds the relationship between metabolic decline and fatty liver disease. The purpose of this study was to evaluate the effect of hepatic steatosis (HS) on the transition from metabolically hea...
Setor K Kunutsor,Reyhaneh Rikhtehgaran,Yanning Xu et al. Setor K Kunutsor et al.
Introduction: The metabolic vulnerability index (MVX)-a composite biomarker reflecting metabolic malnutrition and inflammation-has been linked to increased mortality risk in populations with cardiovascular disease. Thyroi...
Parisa Saberi-Hasanabadi,Fatemeh Shaki,Mohammad Karami et al. Parisa Saberi-Hasanabadi et al.
Aim: Despite advances in diabetes treatments, the effects of this disease have not yet been adequately reversed or prevented in patients. Therefore, development of more effective medication-assisted treatments in this fie...
Anfal Al-Dalaeen,Nour Batarseh,Sally Atawneh Anfal Al-Dalaeen
Background: The consumption of a cafeteria diet is described as deleterious to cognitive performance, potentially due to inducing inflammation in the brain. Cardamom, a potent antioxidant, may benefit brain health. In the...
Kexuan Ren,Xiaofeng Li Kexuan Ren
Objective: Diabetic retinopathy (DR) is characterised by chronic neuroinflammation where the NLRP3 inflammasome plays a pivotal role. This study investigated the therapeutic potential and underlying mechanism of combining...
Sidsel Hastrup,Jakob N Hedegaard,Grethe Andersen et al. Sidsel Hastrup et al.
Aims: Cardiovascular outcome trials have demonstrated that glucagon-like peptide-1 receptor agonists (GLP-1 RA) and sodium-glucose cotransporter 2 inhibitors (SGLT2i) reduce the risk of major adverse cardiovascular events...
Mansour Bahardoust,Sheida Shokohyar,Ali Delpisheh et al. Mansour Bahardoust et al.
Background: The relationship between the triglycerides-to-high-density lipoprotein cholesterol (TG/HDL-C) ratio and the risk of developing chronic kidney disease (CKD) remains unclear, as CKD is a major health challenge w...
Mansour Bahardoust,Sheida Shokohyar,Farzad Maleki et al. Mansour Bahardoust et al.
Background: Previous studies have reported inconsistent findings regarding the relationship between socioeconomic status (SES) inequalities and comorbidities in patients with diabetes mellitus (DM). This systematic review...
Hamza A Abdul-Hafez,Ameer Awashra,Sosana Bdir et al. Hamza A Abdul-Hafez et al.
Background: Tirzepatide, a dual GIP/GLP-1 receptor agonist, offers a novel cardiometabolic strategy beyond glycemic control with important implications for heart failure care. By producing potent, sustained weight reducti...